Assessment of seizures and related symptomatology in persons with mental retardation

Behavior Modification

Volumn 28, Issue 5, 2004, Pages 678-693

  Mayville, Erik A ^a,b   Matson, Johnny L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Mental retardation; Seizures

Indexed keywords

BEHAVIOR MODIFICATION; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ENVIRONMENTAL FACTOR; EPILEPSY; FUNCTIONAL ASSESSMENT; GRAND MAL EPILEPSY; HUMAN; INTELLIGENCE QUOTIENT; INTERVIEW; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL STAFF; MENTAL DEFICIENCY; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOMETRY; RATING SCALE; REVIEW; SCORING SYSTEM; SEIZURE SUSCEPTIBILITY; BEHAVIOR THERAPY; CHRONIC BRAIN DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; INTELLIGENCE; PATIENT CARE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT;

BEHAVIOR THERAPY; BRAIN DAMAGE, CHRONIC; COMORBIDITY; CROSS-SECTIONAL STUDIES; EPILEPSY; HUMANS; INTELLIGENCE; MENTAL RETARDATION; PATIENT CARE TEAM; RISK ASSESSMENT;

EID: 5044246837     PISSN: 01454455     EISSN: None     Source Type: Journal    
DOI: 10.1177/0145445503259839     Document Type: Review

References (46)

1. Alvarez, N., Besag, F., & Iivanainen, M. (1998). Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research, 42, 1-15.
2. Alvarez, N., Kern, R. A., Cain, N. N., Coulter, D. L., Iivanainen, M., & Plummer, A. T. (1998). Antiepileptics. In S. Reiss & M. G. Aman (Eds.), Psychotropic medications and developmental disabilities: The international consensus handbook. Columbus, OH: The Ohio State University Nisonger Center.
3. Antebi, D., & Bird, J. (1993). The facilitation and evocation of seizures: A questionnaire study of awareness and control. British Journal of Psychiatry, 162, 759-764.
4. Bird, J. (1997). Epilepsy and learning disabilities. In O. Russell (Ed.), The psychiatry of learning disabilities (pp. 223-244). London: Gaskell.
5. Bruno-Golden, B., & Holmes, G. L. (1993). Hyperventilation-induced seizures in mentally impaired children. Seizure, 2, 229-233.
6. Cadman, D., Boyle, M., Szatmari, P., & Offord, D. R. (1987). Chronic illness, disability, and mental and social well-being: Findings of the Ontario Child Health Study. Pediatrics, 79, 805-813.
7. Cramer, J. A., & Mattson, R. H. (1993). Quantitative approaches to seizure severity. In H. Meinardi, J. A. Cramer, G. A. Baker, & A. Martins da Silva (Eds.), Quantitative assessment in epilepsy care (pp. 55-71). New York: Plenum.
8. Cramer, J. A., Smith, D. B., Mattson, R. H., Delgado-Escueta, A. V., Collins, J. F., Browne, T. R., et al. (1983). A method of quantification for the evaluation of antiepileptic drug therapy. Neurology, 33(Suppl.), 26-37.
9. Dahl, J. (1992). Epilepsy: A behavior medicine approach to assessment and treatment in children. Seattle: Hogrefe & Huber.
10. Dahl, J. (1999). A behaviour medicine approach to epilepsy - time for a paradigm shift? Scandinavian Journal of Behaviour Therapy, 28, 97-114.
11. Deb, S. (2000). Epidemiology and treatment of epilepsy in patients who are mentally retarded. CNS Drugs, 13, 117-128.
12. Dreyfuss, F. E. (1981). Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia, 22, 249-260.
13. Durand, V. M., & Crimmins, D. B. (1988). Identifying the variables maintaining self-injurious behavior. Journal of Autism and Developmental Disorders, 18, 99-117.
14. Eckoldt, C. S., Matson, J. L., Combs, D. R., Mayville, E. A., Bielecki, J., Smalls, Y., et al., (2000, November). The development of an assessment instrument for the identification of seizures and anti-epileptic medication side-effects. Poster presented at the 34th annual meeting of the Association for Advancement of Behavior Therapy, New Orleans, LA.
15. Efron, R. (1957a). The effect of olfactory stimuli in arresting uncinate fits. Brain, 79, 267-281.
16. Efron, R. (1957b). The conditioned inhibition of uncinate fits. Brain, 80, 251-262.
17. Fenwick, P. (1994). The behavioral treatment of epilepsy generation and inhibition of seizures. Neurologic Clinics, 12, 175-202.
18. Forster, F. M. (1977). Reflex epilepsy, behavior therapy, and conditional reflexes. Springfield, IL: Charles C Thomas.
19. Gadow, K. D., & Poling, A. G. (1988). Pharmacotherapy and mental retardation. Boston: College Hill.
20. Hanson, R. H., Nord, G. B., & Weiseler, N. A. (1997). Length of life: A ten year retrospective study of 209 clients who died in Minnesota's state facilities for persons with developmental disabilities in the 1980's. Journal of Developmental and Physical Disabilities, 9, 39-46.
21. Herranz, J. L., Arteaga, R., & Armijo, J. A. (1982). Side effects of sodium valproate in monotherapy controlled by plasma levels: A study in 88 pediatric patients. Epilepsia, 23, 203-214.
22. Hoare, P. (1984). The development of psychiatric disorder among school children with epilepsy. Developmental Medicine and Child Neurology, 26, 3-13.
23. Iivanainen, M. (1999). Diagnosing epilepsy in patients with mental retardation. In M. Silanpaa, L. Gram. & S. I. Johannessen (Eds.), Epilepsy and mental retardation. Philadelphia: Wrightson Biomedical Publishing.
24. Iwata, B., & Lorentzson, A. (1976). Operant control of seizure-like behavior in an institutionalized retarded adult. Behavior Therapy, 7, 247-251.
25. Kalachnik, J. E. (1999). Measuring side effects of psychopharmacologic medications in individuals with mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5, 348-359.
26. Kalachnik, J. E., Hanzel, T. E., Harder, S. R., Bauernfeind, J. D., & Engstrom, E. A. (1995). Antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques. Mental Retardation, 33, 374-382.
27. Keyser, A. (1993). Seizure frequency as treatment effect parameter in epileptic patients: A critical appraisal of the clinimetric approach. In H. Meinardi, J. A. Cramer, G. A. Baker, & A. Martins da Silva (Eds.), Quantitative assessment in epilepsy care (pp. 43-47). New York: Plenum.
28. Kraft, K. M., & Poling, A. D. (1982). Behavioral treatments of epilepsy: Methodological characteristics and problems of published studies. Applied Research in Mental Retardation, 3, 151-162.
29. Martins da Silva, A., Lourenco, E., Nunes, J. M., & Mendoca, D. (1993). Seizure frequency as treatment effect parameter. In H. Meinardi, J. A. Cramer, G. A. Baker, & A. Martins da Silva (Eds.), Quantitative assessment in epilepsy care (pp. 35-42). New York: Plenum.
30. Matson, J. L. (1995). Manual for the Matson evaluation of social skills for individuals with severe retardation. Baton Rouge, LA: Scientific Publishers.
31. Matson, J. L. (2000). Manual for the Scale for the Evaluation and Identification of Seizures, Epilepsy, and Anticonvulsant Side Effects. Baton Rouge, LA: Disability Consultants, LLC.
32. Matson, J. L., & Baglio, C. S. (1998). Administrator's manual: Matson Evaluation of Drug Side Effects (MEDS). Baton Rouge, LA: Scientific Publishers.
33. Matson, J. L., & Bamburg, J. W. (1998). Reliability of the assessment of dual diagnosis. Research in Developmental Disabilities, 19, 89-95.
34. Matson, J. L., Bamburg, J. W., Mayville, E. A., & Kahn, I. K. (1999). Seizure disorders in persons with intellectual disability: An analysis of differences in social functioning, adaptive functioning, and maladaptive behaviors. Journal of Intellectual Disability Research, 43, 531-539.
35. Matson, J. L., Gardner, W. I., Coe, D. A., & Sovner, R. (1991). A scale for evaluating emotional disorders in severely and profoundly mentally retarded persons: Development of the diagnostic assessment for the severely handicapped. British Journal of Psychiatry, 159, 404-409.
36. Matson, J. L., Helsel, W. J., Bellack, A. S., & Senatore, V. (1983). Development of a rating scale to assess social skill deficits in mentally retarded adults. Applied Research in Mental Retardation, 4, 399-407.
37. Matson, J. L., LeBlanc, L. A., Weinheimer, B., & Cherry, K. E. (1999). Reliability of the Matson Evaluation of Social Skills for Individuals with Severe Retardation (MESSIER). Behavior Modification, 23, 647-661.
38. Matson, J. L., Mayville, E. A., Bamburg, J. W., & Eckoldt, C. S. (2001). An analysis of side effect profiles of anti-seizure medications for persons with mental retardation using the Matson Evaluation of Side Effects (MEDS). Journal of Intellectual and Developmental Disorders, 26, 283-295.
39. Matson, J. L., Mayville, E. A., Bielecki, J., Barnes, W. H., Bamburg, J. W., & Baglio, C. (1998). Reliability of the Matson Evaluation of Drug Side Effects Scale (MEDS). Research in Developmental Disabilities, 19, 501-506.
40. Matson, J., Vollmer, T., Paclawskyj, T., Smirolodo, B., Applegate, H., & Stallings, S. (1996). Questions About Behavior Function (QABF): An instrument to assess functional properties of problem behaviors. Poster presented at the 22nd Annual Convention of the Association for Behavior Analysis, San Francisco, CA.
41. Mattson, R. H., Cramer, J. A., Collins, J. F., Smith, D. B., Delgado-Escueta, A. V., Browne, T. R., et al. (1985). Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine, 313, 145-151.
42. Mayville, E. A. (2001). The Matson and Mayville (M&M) seizure scale: An assessment of psychological and environmental variables contributing to seizure activity in persons with mental retardation. Unpublished doctoral dissertation, Louisiana State University, Baton Rouge, LA.
43. Reiss, S. (1990). The development of a screening measure for psychopathology in people with mental retardation. In E. Dibble & D. Gray (Eds.), Assessment of behavior problems in persons with mental retardation living in the community. Rockville, MD: National Institute of Mental Health.
44. Reid, A. H., Naylor, G., & Kay, D. S. G. (1981). A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychological Medicine, 11, 109-113.
45. Viteri, C., & Martinez-Lage, J. M. (1993). Seizure severity as treatment effect parameter. In H. Meinardi, J. A. Cramer, G. A. Baker, & A. Martins da Silva (Eds.), Quantitative assessment in epilepsy care (pp. 49-54). New York: Plenum.
46. Zlutnick, S., Mayville, W. J., & Moffat, S. (1975). Modification of seizure disorders: The interruption of behavioral chains. Journal of Applied Behavior Analysis, 8, 1-12.